News

Two important studies were released at the Late Breaking Clinical Trials session II at EHRA EUROPACE 2013. The PREFER AF study(2) found that oral anticoagulation is now used in over 85% of patients with atrial fibrillation (AF) eligible for...

St. Jude Medical, Inc., a global medical device company, announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and launch of the Accent MRI™ Pacemaker and the Tendril MRI™ lead. Unlike MRI-labeled...

The Mount Sinai Medical Center is the first medical center in New York City to offer the newly FDA approved HeartMate II® Pocket Controller™ to help its advanced heart failure patients maintain more active lifestyles. This latest generation...

Prospective, Multicenter Study of 532 Case Matched Patients Showed 100% Reduction in Infections Athens, Greece (June 26, 2013): Use of TYRX, Inc.’s AIGISRx® Antibacterial Envelope reduced major infection rates by 100% in patients undergoing...

Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and leader in the treatment of cardiovascular diseases, announces the first U.S. implant of its PARADYM SonR CRT System for the RESPOND CRT IDE Clinical Trial. Dr....

BIOTRONIK, the leading manufacturer of cardiovascular medical technology celebrating its 50th anniversary this year, announced the European market launch of its Ilesto 7 Series. Ilesto 7 is the world’s first DF4 ICD/CRT series approved for...

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it will display the LifeVest® Wearable Defibrillator, along with sudden cardiac death (SCD) education and screening tools, in Booth...

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced CE mark approval and the European commercial launch of the REPLY ™ 200 family of pacemakers featuring Sleep Apnea Monitoring (SAM)2.The...

A leading German cardiovascular heart center reported promising mid-term results for the surgical treatment of persistent atrial fibrillation (Afib) during last week’s International Society for Minimally Invasive Cardiothoracic Surgery...

The BIOTRONIK DX System, a first-in-class implantable cardiac defibrillator (ICD) providing dual-chamber diagnostic capabilities with a single lead, was one of 14 medical innovations on display in front of thousands of healthcare providers...